A retrospective review of paediatric adverse drug reactions reported in Lombardy and Croatia from 2005 to 2013

Carla Carnovale, Marta Gentili, Marco Matacena, Marina Dimov Di Giusti, Darko Krnic, Barbara Dolinic, Darija Kolaric, Zeljana Margan Koletic, Viola Macolic Sarinic, Maja Culjak, Ida Fortino, Luca Merlino, Emilio Clementi, Sonia Radice

Research output: Contribution to journalArticlepeer-review


Objective: to characterise the adverse drugs reactions (ADRs) reported in the Lombard and Croatian paediatric population and to compare data to specific paediatric age groups, in terms of trend, pattern and severity of ADRs, increasing understanding of paediatric ADRs. Research design and methods: We selected and analysed all the spontaneous reports in which children were involved (0 < 18 years old) reported in the Lombardy and in Croatian pharmacovigilance databases from 1th March 2005 to 31th December 2013. Results: 9175 ADR reports were reported in the Lombardy, 2457 were included in the Croatian database. The age groups most involved were 2–11 for both countries. The 13.2% and 40.3% of reports retrieved in Lombardy and Croatia were classified as serious, respectively. Fatalities account for 0.09% and 0.12% in Lombardy and Croatia, respectively. Conclusion: Data on serious reports reflect a similar scenario in terms of age range; strikingly different therapeutic subgroups were involved in reporting activity likely due to greater self-medication practices with penicillins and anti-inflammatory, analgesic and antipyretics drugs in Lombardy than in Croatia, highlighting the need to closely monitor this paediatric therapeutic area to ensure a safe use of these drugs.

Original languageEnglish
Pages (from-to)35-43
Number of pages9
JournalExpert Opinion on Drug Safety
Publication statusPublished - Dec 1 2016


  • Adverse drug reaction
  • children
  • paediatrics
  • pharmacovigilance

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'A retrospective review of paediatric adverse drug reactions reported in Lombardy and Croatia from 2005 to 2013'. Together they form a unique fingerprint.

Cite this